Test Price
2,800 AED✅ Home Collection Available
COL3A1 Gene Ehlers-Danlos Syndrome Type 3 Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM – 11 PM daily).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The COL3A1 gene test utilizes advanced Next-Generation Sequencing (NGS) to identify pathogenic mutations associated with vascular Ehlers-Danlos syndrome (vEDS). This test enables definitive diagnosis, targeted surveillance, and family risk assessment through full gene sequencing and copy number variant (CNV) detection.
| Feature | Our Test (COL3A1 NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Method Precision | Full gene sequencing + CNV detection | Targeted exon sequencing only |
| Analytical Sensitivity | >99% for SNVs/indels, CNVs included | ~95% for selected exons |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
Physician Insight & Safety Protocols
"This test uncovers silent vascular risk. A negative result does not exclude all EDS subtypes; clinical correlation with skin and vascular imaging remains essential. I encourage you to discuss every outcome with your physician to build a personalised care plan."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
⚠ Important Clinical Advisory
Do not discontinue any prescribed medication without first consulting your treating doctor. Genetic results may influence long-term management, not acute therapy. A mandatory genetic counseling session is required prior to sample collection.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Active bleeding disorder, inability to provide informed consent, acute severe cardiovascular event within last 30 days.
- Absolute Contraindication for Blood Draw: Cellulitis or infection at phlebotomy site.
- Emergency Red Flags — seek immediate care if: sudden tearing chest or abdominal pain, unexplained collapse, new severe bruising or arterial rupture symptoms.
All genetic testing follows UAE Federal Decree-Law No. 4 of 2016 on Medical Liability and informed consent protocols.
Patient FAQ & Clinical Guidance
1. What is the purpose of the COL3A1 gene test for Ehlers-Danlos syndrome type 3?
This identifies mutations in COL3A1 that cause vascular Ehlers-Danlos syndrome, enabling early detection of life-threatening arterial fragility. Early diagnosis allows for proactive surveillance and family screening.
2. How is the sample collected and are there special preparations?
A small blood sample is drawn via VIP mobile phlebotomy at your home; no fasting or medication adjustments are required. Genetic counseling is mandatory before testing to ensure informed consent.
3. What actions should I take if the result is positive?
A positive result requires immediate consultation with a vascular specialist and genetic counsellor to establish a surveillance plan and consider family screening. Regular monitoring including echocardiography and vascular imaging is recommended.
UAE Regulatory & Data Privacy Adherence
Data Protection & Compliance Framework
All genetic data is processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Your genomic information is encrypted, access-restricted, and never shared without explicit written consent.
Clinical & Logistical Metadata
| Test Name | COL3A1 Gene Ehlers-Danlos Syndrome Type 3 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (3–5 mL in EDTA tube) |
| Methodology Used | Next-Generation Sequencing (NGS) with CNV analysis |
| ICD-10-CM Code | Q79.6 |
| LOINC Code | 21636-6 |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians